Literature DB >> 18444913

The number of activating KIR genes inversely correlates with the rate of CMV infection/reactivation in kidney transplant recipients.

M Stern1, H Elsässer, G Hönger, J Steiger, S Schaub, C Hess.   

Abstract

Viral infection is a common complication after kidney transplantation. The role of natural killer cells (NK cells) in this setting remains unknown. NK cells express activating and inhibitory killer cell immunoglobulin-like receptors (KIR). We analyzed whether activating KIR genes carried by kidney transplant-recipients influence the rate of viral infection during the first year after transplantation. In patients with a KIR A/A genotype (n = 40, KIR2DS4 only activating KIR) the rate of cytomegalovirus (CMV) infection and reactivation was 36%, as compared to 20% in transplant recipients with more than one activating KIR gene (KIR B/X genotype, n = 82, p = 0.04). Adjusting for other risk factors in Cox regression, the relative risk of B versus A genotype patients was 0.34 (95% CI 0.15-0.76, p = 0.009). The degree of protection increased with the number of activating KIR genes. Symptomatic CMV disease was only observed in four individuals, all carrying a KIR A/A genotype. As for viral infections other than CMV, and for bacterial infections, no KIR-linked protective effect could be detected. Also, graft function and the rate-rejection episodes were similar in KIR A/A and KIR B/X genotype individuals. This study supports a role for activating KIR in the control of CMV infection after kidney transplantation.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18444913     DOI: 10.1111/j.1600-6143.2008.02242.x

Source DB:  PubMed          Journal:  Am J Transplant        ISSN: 1600-6135            Impact factor:   8.086


  34 in total

Review 1.  The tortoise and the hare: slowly evolving T-cell responses take hastily evolving KIR.

Authors:  Jeroen van Bergen; Frits Koning
Journal:  Immunology       Date:  2010-08-17       Impact factor: 7.397

2.  NK cell and Th17 responses are differentially induced in murine cytomegalovirus infected renal allografts and vary according to recipient virus dose and strain.

Authors:  Mao Li; Srinivasa Rao Boddeda; Bo Chen; Qiang Zeng; Trenton R Schoeb; Victoria M Velazquez; Masako Shimamura
Journal:  Am J Transplant       Date:  2018-05-07       Impact factor: 8.086

3.  Transcriptional Changes in Kidney Allografts with Histology of Antibody-Mediated Rejection without Anti-HLA Donor-Specific Antibodies.

Authors:  Jasper Callemeyn; Evelyne Lerut; Henriette de Loor; Ingrid Arijs; Olivier Thaunat; Alice Koenig; Vannary Meas-Yedid; Jean-Christophe Olivo-Marin; Philip Halloran; Jessica Chang; Lieven Thorrez; Dirk Kuypers; Ben Sprangers; Leentje Van Lommel; Frans Schuit; Marie Essig; Wilfried Gwinner; Dany Anglicheau; Pierre Marquet; Maarten Naesens
Journal:  J Am Soc Nephrol       Date:  2020-07-08       Impact factor: 10.121

Review 4.  Concise review: immunologic lessons from solid organ transplantation for stem cell-based therapies.

Authors:  Andrea Loewendorf; Marie Csete
Journal:  Stem Cells Transl Med       Date:  2013-01-24       Impact factor: 6.940

Review 5.  BK polyomavirus infection and nephropathy: the virus-immune system interplay.

Authors:  Nina Babel; Hans-Dieter Volk; Petra Reinke
Journal:  Nat Rev Nephrol       Date:  2011-05-24       Impact factor: 28.314

Review 6.  Cytotoxic potential of decidual NK cells and CD8+ T cells awakened by infections.

Authors:  Ângela C Crespo; Anita van der Zwan; João Ramalho-Santos; Jack L Strominger; Tamara Tilburgs
Journal:  J Reprod Immunol       Date:  2016-08-02       Impact factor: 4.054

Review 7.  Biology and clinical effects of natural killer cells in allogeneic transplantation.

Authors:  Jonathan E Benjamin; Saar Gill; Robert S Negrin
Journal:  Curr Opin Oncol       Date:  2010-03       Impact factor: 3.645

8.  KIR3DL1/S1 genotypes and KIR2DS4 allelic variants in the AB KIR genotypes are associated with Plasmodium-positive individuals in malaria infection.

Authors:  Michiko Taniguchi; Masato Kawabata
Journal:  Immunogenetics       Date:  2010-01-05       Impact factor: 2.846

9.  KIR-associated protection from CMV replication requires pre-existing immunity: a prospective study in solid organ transplant recipients.

Authors:  A Gonzalez; K Schmitter; H H Hirsch; C Garzoni; C van Delden; K Boggian; N J Mueller; C Berger; J Villard; O Manuel; P Meylan; M Stern; C Hess
Journal:  Genes Immun       Date:  2014-07-10       Impact factor: 2.676

10.  Donors with group B KIR haplotypes improve relapse-free survival after unrelated hematopoietic cell transplantation for acute myelogenous leukemia.

Authors:  Sarah Cooley; Elizabeth Trachtenberg; Tracy L Bergemann; Koy Saeteurn; John Klein; Chap T Le; Steven G E Marsh; Lisbeth A Guethlein; Peter Parham; Jeffrey S Miller; Daniel J Weisdorf
Journal:  Blood       Date:  2008-10-22       Impact factor: 22.113

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.